← Back to Search

Magnesium Supplementation for Lymphoma

Q: How many subjects are involved in this research study?

<p>Affirmative. Information posted on clinicaltrials.gov states that this clinical trial commenced recruitment on April 15th 2022 and is still actively seeking participants. The study will accept 50 patients at one location.</p>

Q: Does this clinical investigation have any open spots for enrollment at present?

<p>Clinicaltrials.gov's repository of information indicates that this experiment is currently seeking participants, having been posted on April 15th and updated most recently on the 18th of the same month.</p>

Phase < 1

Recruiting

Led By Thomas E. Witzig, M.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0, 1, or 2

Currently have or have had in the past the diagnosis of any type of lymphoma

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline, 28 days, and 56 days

Awards & highlights

Study Summary

This trial looks at whether magnesium replacement through diet and a topical lotion can help keep magnesium blood levels ideal in patients with lymphoma. It also investigates side effects and quality of life.

Who is the study for?

Adults (18+) with any type of lymphoma can join this trial. Eligible participants include those off myelosuppressive chemotherapy for 2+ months, on certain maintenance or oral therapies, and with an ECOG Performance Status of 0-2. They must not have taken magnesium supplements recently, be able to eat a full diet including seeds/nuts, and have no severe illnesses that could affect the study.Check my eligibility

What is being tested?

The trial is exploring if a magnesium-rich diet and topical magnesium lotion can maintain ideal blood magnesium levels in lymphoma patients. It's an early phase I trial where participants will also help assess side effects and how these forms of magnesium impact their quality of life.See study design

What are the potential side effects?

Potential side effects are not detailed but may include skin reactions from the lotion or digestive changes due to the special diet therapy. The study aims to monitor overall well-being through quality-of-life assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can take care of myself and am up and about more than half of my waking hours.

Select...

I have been diagnosed with lymphoma at some point.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, 28 days, and 56 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, 28 days, and 56 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 28 days, and 56 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Improvement in serum magnesium levels

Secondary outcome measures

Feasibility of patient enrollment

Incidence of adverse events

Patient compliance

+1 more

Other outcome measures

Patient Medication Quality of Life Assessment

Relationship between race/ethnicity and differences in diet and serum magnesium levels

Trial Design

3Treatment groups

Experimental Treatment

Group I: Cycle 2, Arm IIExperimental Treatment2 Interventions

Participants continue consuming magnesium rich foods PO daily for 28 days.

Group II: Cycle 2, Arm IExperimental Treatment3 Interventions

Participants continue consuming magnesium rich foods PO daily and apply Ancient Minerals Magnesium Lotion topically daily for 28 days.

Group III: Cycle 1Experimental Treatment2 Interventions

Participants consume magnesium rich foods PO daily for 28 days.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,221 Previous Clinical Trials

3,767,892 Total Patients Enrolled

63 Trials studying Lymphoma

27,995 Patients Enrolled for Lymphoma

National Cancer Institute (NCI)NIH

13,680 Previous Clinical Trials

40,927,245 Total Patients Enrolled

1,387 Trials studying Lymphoma

382,509 Patients Enrolled for Lymphoma

Thomas E. Witzig, M.D.Principal InvestigatorMayo Clinic in Rochester

2 Previous Clinical Trials

78 Total Patients Enrolled

2 Trials studying Lymphoma

78 Patients Enrolled for Lymphoma

Media Library

Special Diet Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05294367 — Phase < 1

Lymphoma Research Study Groups: Cycle 1, Cycle 2, Arm I, Cycle 2, Arm II

Lymphoma Clinical Trial 2023: Special Diet Therapy Highlights & Side Effects. Trial Name: NCT05294367 — Phase < 1

Special Diet Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05294367 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects are involved in this research study?

"Affirmative. Information posted on clinicaltrials.gov states that this clinical trial commenced recruitment on April 15th 2022 and is still actively seeking participants. The study will accept 50 patients at one location."

Answered by AI

Does this clinical investigation have any open spots for enrollment at present?

"Clinicaltrials.gov's repository of information indicates that this experiment is currently seeking participants, having been posted on April 15th and updated most recently on the 18th of the same month."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

2022. "Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05294367.